Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.
Study offers insights into who’s at risk for long COVID among immunocompromised patients
- Post author:
- Post published:January 27, 2024
- Post category:uncategorized